EUVIMEDEUVIMED entdecken
EditorialKommentar

Optimal Antiplatelet Therapy Revisited

Deepak L Bhatt

Journal of the American College of Cardiology · 2023-02 · 81 (6) · 553-556

DOI: 10.1016/j.jacc.2022.11.040 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of the American College of Cardiology, 2023-02. Verfasst von Deepak L Bhatt. Beteiligte Einrichtung: Mount Sinai Heart, Icahn School of Medicine at Mount Sinai Health System, New York, New York, USA. Electronic address: DLBhattMD@post.Harvard.edu. Hauptthemen laut MEDLINE: Myocardial Infarction, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionPercutaneous Coronary InterventionHumansPlatelet Aggregation InhibitorsAspirinDrug Therapy, CombinationTreatment OutcomePurinergic P2Y Receptor Antagonists

Stichwörter der Autor:innen

DAPTP2Y(12) inhibitorscomplex PCImeta-analysispercutaneous coronary intervention

Substanzen

Platelet Aggregation InhibitorsAspirinPurinergic P2Y Receptor Antagonists

Autor:innen und Institutionen

  • Mount Sinai Heart, Icahn School of Medicine at Mount Sinai Health System, New York, New York, USA. Electronic address: DLBhattMD@post.Harvard.edu.

Zitieren

APA

Bhatt, D. L. (2023). Optimal Antiplatelet Therapy Revisited. Journal of the American College of Cardiology, 81(6), 553-556. https://doi.org/10.1016/j.jacc.2022.11.040

Vancouver

Bhatt DL. Optimal Antiplatelet Therapy Revisited. Journal of the American College of Cardiology. 2023;81(6):553-556. doi:10.1016/j.jacc.2022.11.040

BibTeX
@article{Bhatt2023,
  author = {Bhatt, Deepak L},
  title = {Optimal Antiplatelet Therapy Revisited},
  journal = {Journal of the American College of Cardiology},
  year = {2023},
  volume = {81},
  number = {6},
  pages = {553--556},
  doi = {10.1016/j.jacc.2022.11.040}
}
Kostenlos starten →